Drugs/Indications

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

EXPLORE : Most Read News All News All Webcasts / CME All Cases Congress Resource Centre All Medical Resources My Personal Edition

Recently Approved Drugs/Indications

11/06/2009	FDA Approves Romidepsin Injection for Previously Treated T-Cell Lymphoma
11/02/2009	FDA Approves Exenatide as First-Line Treatment for Type 2 Diabetes
10/27/2009	Rilonacept Approved in the EU for Cryopyrin-Associated Periodic Syndromes
10/27/2009	FDA Grants Accelerated Approval to Ofatumumab for Refractory Chronic Lymphocytic Leukaemia
10/26/2009	FDA Authorises Emergency Use of Intravenous Peramivir for Certain Hospitalised Patients With H1N1 Influenza
10/19/2009	FDA Approves Pazopanib for Advanced Renal Cell Carcinoma
10/19/2009	FDA Approves New Seasonal Influenza Vaccine for Paediatric Use
10/19/2009	FDA Approves Telmisartan, Amlodipine Combination Tablets for Hypertension
10/19/2009	FDA Approves Telmisartan to Reduce Risk of Cardiovascular Events in High-Risk Patients
10/19/2009	FDA Approves Rasburicase for Management of Hyperuricemia in Patients With Haematologic Malignancies
10/19/2009	FDA Approves HPV Recombinant Vaccine, Types 16 and 18
10/16/2009	FDA Approves HPV Vaccine for Prevention of Genital Warts in Boys, Young Men
10/12/2009	Zanamivir Dry Powder Should Not Be Delivered by Nebuliser, FDA Warns
10/12/2009	FDA Approves a C1-Esterase Inhibitor for Abdominal Attacks, Facial Swelling Associated With HAE
10/09/2009	FDA Conducting Safety Investigation of CT Brain Perfusion Scans
10/07/2009	FDA Approves Colesevelam HCl for Children With Familial Hypercholesterolemia
10/01/2009	FDA Approves Levonorgestrel IUD to Treat Heavy Menstrual Bleeding
10/01/2009	Health Canada Approves Telavancin for Complicated Skin, Skin Structure Infections
10/01/2009	New USP Standards for Heparin Products Will Result in Decreased Potency
09/25/2009	FDA Conducting a Safety Review of Deferasirox Due to Reported Adverse Events
09/25/2009	FDA Approves Ustekinumab for Moderate to Severe Psoriasis
09/25/2009	FDA Recommends Labelling Change for Sitagliptin to Include Risk of Pancreatitis
09/25/2009	FDA Approves Pralatrexate Injection for Relapsed, Refractory Peripheral T-Cell Lymphoma
09/25/2009	FDA Warns of Potential Dosing Errors With Oseltamivir
09/22/2009	FDA Continues to Receive Reports of PML in Patients Receiving Natalizumab
09/17/2009	FDA Approves Single Pill Combination of Valsartan, Aliskiren for Hypertension
09/16/2009	FDA Requires Boxed Warning for Promethazine Hydrochloride Injection
09/16/2009	FDA Approves Ganciclovir Ophthalmic Gel for Herpetic Keratitis
09/15/2009	FDA Approves Four Vaccines for the 2009 Influenza A(H1N1) Virus
09/14/2009	Once-Daily Lopinavir/Ritonavir Tablet Approved in EU for Treatment-Na�ve HIV Patients